Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | ID-LV305 |
| Trade Name | |
| Synonyms | LV305 |
| Drug Descriptions |
ID-LV305 is a modified lentiviral vector encoding human tumor-associated cancer-testis antigen (NY-ESO-1) which may stimulates immune response against NY-ESO-1-expressing tumor cells (PMID: 31227504). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C115976 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Aldesleukin + CMB305 + Cyclophosphamide + ID-LV305 | Aldesleukin CMB305 Cyclophosphamide ID-LV305 | 0 | 1 |
| Aldesleukin + Cyclophosphamide + ID-LV305 | Aldesleukin Cyclophosphamide ID-LV305 | 0 | 1 |
| G305 + ID-LV305 | G305 ID-LV305 | 0 | 1 |
| ID-LV305 | ID-LV305 | 0 | 1 |